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Background: Large intestine malignances basically can be defined as cancer of the large 
bowel. It includes all malignant conditions originating from the ileocaecal valve down to 
the anus. In the year 2000, colorectal cancer was ranked the third most common form of 
cancer in adults world-wide in terms of incidence. This study aimed to document the profile 
of large intestine malignancies and early treatment outcomes among patients attended in 
major hospitals in Dar es Salaam, Tanzania. 
Methods: This was a one year hospital based retrospective cross sectional study conducted 
by using a structured data collecting tool. The data were analyzed using SPSS software. 
Results: A total of102 patients with Large intestine malignances were enrolled in our study. 
Both sexes were affected equally. The overall mean age was 51.23 (SD ± 15.5) years with a 
range of 22 to 80 years with those aged between 60 to 79 being the most affected group by 
40.2%. Most tumours were located in the rectum and anal canal constituting 49.3% in 
males and 50.7% in females.  DUKES C accounted for 79.4% of the cases with 
Adenocarcinoma being the commonest histopathological diagnosis accounting for 82.4% of 
the cases with Colo-Rectal tumours. Hemicolectomy was the most performed surgery by 
57.1% with good outcomes at a follow up of thirty days. Only one death occurred in patient 
who underwent a low anterior resection.   
Conclusion: From our study Large bowel malignancy is no longer a rare condition with no 
gender bias. Majority of our patients with large intestine malignances still presents with 
advanced disease, we therefore call for high index of suspicion among clinicians for early 
diagnosis and prompt treatment to improve survival of patients. 
Key words: Large intestine malignances, treatment outcome 
Introduction  
The large intestine extends from the ileocaecal valve to the anus. It is divided anatomically and 
functionally into the colon, rectum and anal canal. Large intestine malignances can be 
subdivided into colon cancer, which ranges from caecum to the sigmoid colon, rectal cancer that 
involves the rectum and anal cancer within the anal canal1-4.  In the year 2000, colorectal cancer 
was ranked the third most common form of cancer in adults world-wide in terms of incidence 
(after prostate and lung cancer in males and  breast and lung cancer in females)5. Among both 
men and women, incidence rates were nearly fourfold higher in more-developed compared with 
less-developed countries of the World, whereas mortality rates were only two-and-a half-fold 
higher6. In United States about 72% of cases arise in the colon and about 28% in the rectum3.  
Anal canal cancer usually appears in the 6th and 7th decades of life with prevalence double in 
women compared to men, mainly attributed to Human Papilloma Virus (HPV) infections6.  An 
increase has also been found in geographical areas where HIV prevalence is high, and among 
homosexuals6. Worldwide it is estimated that 30,400 new cases of anal canal cancer occur 
annually with 15,900 cases in developing countries and 14,500 in developed countries3,6. The 
lowest rates of colorectal cancer are reported to occur in Sub-Saharan Africa, South America and 
Asia, but they are said to be on the increase in these countries probably due to change in life-
style and dietary habits7. 
The major clinical features of large intestines malignances are rectal bleeding, change in bowel 
habits, abdominal pain, bowel obstruction, weight loss, anorexia, anaemia, tenesmus and rectal 
mass depending on the site of location of the tumor. Silently, patient may have occult blood in 
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stool, and persistent anaemia8-9. The diagnosis of large intestine malignances, as with all 
malignancies, requires a high index of suspicion and diligent follow-up of all symptoms, 
especially in high-risk individuals10. A logical approach to early diagnosis is through routine 
screening tests. The most widely used screening tests for asymptomatic individuals are: Digital 
rectal examination (DRE) which is inexpensive and useful form of examination as well as Feacal 
Occult Blood Test (FOBT) used to detect tiny amounts of invisible blood in the stool. Blood 
vessels at the surface of colorectal polyps or cancers are often fragile and easily damaged by the 
passage of feaces11. Proctosigmoidoscopy, Colonoscopy and Double contrast barium enema 
studies are useful for diagnosis12. 
 
Management of large intestine malignances is based on the location and the stage of the tumor. 
Cancer of colon is a highly treatable and often curable disease when localized to the bowel.13 
Standard treatment of colon cancer has been surgical resection of the primary and regional 
lymph nodes for localized disease and the procedure results in cure in approximately 50% of 
patients13. Laparoscopic resection has been employed and found to yield the same results as 
open resections for such lesions14. Regional lymph node dissection needs to be performed to 
determine staging, which guides decisions about adjuvant therapy. Up to 20% of isolated 
hepatic metastasis may be cured with resection or cryosurgical ablation of hepatic lesion15-16. 
Even patients with extensive metastatic disease may benefit from resection of colonic tumors to 
reduce the likelihood of intestinal obstruction or serious bleeding13, 15. 
 
For rectal carcinoma, the operative approach depends upon the level of the tumor proximal to 
the anal verge, the size of the tumor, the depth of penetration and the patient’s general 
condition. For patients with less than 3 cm, well-differentiated, less than 7.5 cm from the anal 
verge shown by endosonography and CT imaging to be localized to the rectal wall, trans-anal 
excision may be the surgery of choice13. All other patients require either a low anterior 
resection with colorectal anastomosis or an Abdomino-perineal resection (APR) with a terminal 
colostomy, depending on how far above the anal verge the tumor is located13. Both 
respectability and operability of rectal tumors have been shown to be improved by Neo-
adjuvant radiotherapy followed by Total Mesorectal Excision (TME). The use of staplers has also 
improved functional outcome and quality of life after rectal surgery by bowel anastomosis 
instead of a permanent colostomy. 
 
Adjuvant chemotherapy and radiotherapy have been demonstrated to improve overall disease 
free survival in selected patients with large intestines malignances. Patients with stage I colon 
cancer have excellent 5-year survival rates (80-100%) and no adjuvant therapy is 
recommended. Usually patients with advanced stage II and stage III benefit most with 
postoperative adjuvant chemotherapy. There is evidence that stage III patients have 33% 
reduction in mortality with adjuvant therapy. Stage IV patients can also benefit from adjuvant 
chemotherapy13, 17.  
 
Recurrence of large intestine malignances following surgery is a major problem and often is the 
ultimate cause of death. So, patients who have undergone resections with curative intention 
should be followed-up closely indefinitely for evidence of tumor recurrence and spread13. The 
use of tumor markers before initiation of therapy is very important in the follow up period as 
well as endoscopic procedures that are now readily available in developing countries including 
Tanzania. The characteristics of colorectal and anal cancer patients in Tanzania have not been 
documented and local observation is lamenting on low resection rates of the patients that are 
attended, citing late presentation. The immediate outcome of our patients is also not known. So 
this study aimed to address these gaps and come up with suggestions to improve colorectal and 
anal cancer surgery in Tanzania. 
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Patients and Methods 
A hospital based descriptive, retrospective study was carried out in five major hospitals in Dar 
es Salaam that perform large intestines cancer surgery, only one being a public facility, namely 
Muhimbili National Hospital, TMJ, Hindu Mandal, Tumaini, and Aga Khan hospitals for a period 
of eleven months. Those that were referred to the only cancer institute were also followed up to 
their discharge. There was no direct patient contact, treatment records was obtained by 
reviewing their case notes where information regarding age, location of tumor, histological 
confirmation, HIV status, treatment offered, dukes classification and immediate outcome. All 
patients with histological confirmation of malignancy of the large intestines were included in 
the study.  
The study protocol was presented to IRB of Muhimbili University of Health and Allied Sciences, 
MUHAS, where approval was obtained. This study carried no risk to the patients as only their 
records were being reviewed, but had the benefits of showing deficiencies in our practice for the 
benefit of future patients with large intestines malignancy. No direct patients’ identifiers were 
used in this study, and confidentiality was maintained even after the study period. Data was 
collected using a structured questionnaire, cleansed, coded and entered into EPI Info 2002 and 
exported into SPSS version 16 for analysis where cross-tabulations were generated. This study 
did not look at why surgery was not offered to patients, no views of surgeons was gathered, 
patients risk factors not assessed and reason for patients refusing proposed treatment and the 
nature of the proposed treatment. 
 
Results 
A total of 102 patients were treated for large intestines malignancy during the period of 12 
months with equal sex distribution. The age ranged from 22 to 80 with a mean of 51.2±15.5, 
with the mean age in males lower than in females at 50.5 (SD ± 15.8) years and 51.9 (SD ± 15. 2) 
years respectively. Over a quarter of the study subjects were below forty years of age while the 
majorities were sixty years and above at 43(42.1%) (Figure 1). Adenocarcinoma was the most 
prevalent histological diagnosis by 84(82.4%), with slight male predominance at 43(51.2%) for 
colorectal cancers, while squamous cell carcinoma was dominant in the anal canal in 13 
(12.7%), with female predominance, 8 (61.5%). Four cases with tumor in the colon and rectum 
respectively had Gastro-Intestinal Stromal Tumors (GIST) one in the sigmoid colon and three 



























Figure 1: Age and sex distribution (n=102) 
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Table 1.  Anatomical Location of the Tumour. 
 
















20 – 39 02 01 0 0 1 23 0 
40 – 59 02 01 01 0 02 25 01 
>60 05 0 0 01 06 31 0 
Sex 
Male 06 01 0 0 05 38 01 
Female 03 01 01 01 04 41 0 
Key:  TC - Transverse colon; DC - Descending colon;  RA- Rectum and Anus 
 
 




CN=81 (%) D N=16 (%) Unclassified 
N=5  
Sex Male 38 (46.9) 10 (62.5) 03  
 Female 43 (53.1) 06 (37.5) 02  
Age group     
 20 – 39 21 (25.9) 04 (25.0) 02  
 40 – 59 25 (30.9) 07 (43.8) 0 
 60 – 79 35 (43.2) 05 (31.2) 03 
 
 
Table 3. Types of Curative Surgical Treatments Offered  
Variable  APR ( 9) LAR(3) HC(16) Total (28) 
 Age group 
20 – 39 02 01 04 07 
40 – 59 03 0 07 10 
>60 04 02 05 11 
Sex 
Male  05 02 09 16 
Female  04 01 07 12 
Death 0 01 0 01 
Key: APR – Abdomino-Perineal Resection, LAR: Low Anterior Resection, HC: Hemi-Colectomy 
Only one case of Melanoma of the anal canal was also found. Majority of the study subjects had 
tumors in the Anorectal region, 79 (77.5%) most of whom were sixty years and above. Slightly 
more female patients had tumors in that region at 41 (51.9%) (Table 1). Nearly all patients with 
colorectal tumours, 95.1%, had Dukes staging performed with the majority being in stage C, 
81(79.4%), followed stage D by 16 cases (15.7%) of which 12 were due to liver metastasis and 
four lung metastasis (Table 2). 
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Only 28 (27.5%) of the patients had tumor resection done with Hemicolectomy being the most 
performed procedure in 16 (57.1%), followed by Abdomino-perineal resection in 9 (32%) and 
the least was Low anterior resection in 3 (10.7%). All the surviving patients were referred for 
chemoradiotherapy. Forty seven patients received palliative treatments in the form of 
colostomy and chemoradiation (Table 3).  
Discussion 
While this study did not aim to document on the incidence of colorectal and anal malignancy, it 
has shown that the problem might be of significant health concern to health planners. The study 
has shown that these cancers affect people in their middle age of life when they are still 
productive and useful to their societies, contrasting with most studies which have reported the 
disease to be occurring in advances of age18-24.  A quarter of the study patients were well below 
forty years of age, but it was not uncommon among those over sixty years. This pattern is 
difficult to explain in this study but can be a focus of another study to explore on the risk factors 
for the development of the malignancy including molecular and genetic characteristics of these 
patients. While some studies suggest that large intestines cancer is largely a disease of the 
male7, our study has shown equal sex predilection. This finding is similar to those from India 
and Thailand25-26. While it is postulated that estrogen hormones are protective against the 
cancer, why our women were not protected remains unknown to us and is another area for 
future studies.    
  
Clinically, most of our patients with large intestine cancers presented late making it difficult to 
differentiate between anal tumors extending upwards to the anus or vice versa. Due to this, 
more than two thirds of the tumors were classified as Anorectal which is the most preferred 
terminology here. The second most common site was the sigmoid colon, therefore making left 
sided tumors to be the most common just like in other studies27. Differentiation between anal 
and rectal tumor was then only made after histological diagnosis, where by squamous cell 
carcinoma would be considered as anal in origin and Adenocarcinoma as rectal in origin. In this 
study, Adenocarcinoma constituted more to more than four fifth of the histological diagnosis to 
patients who had colorectal tumours, with slight male predominance. This is similar to other 
studies which have shown that more than three quarters were Adenocarcinoma19. There were 
12.5% cases of squamous cell carcinoma of the anal canal in this study with majority occurring 
in the female population. This in other literature was explained by the occurrence of Human 
Papiloma Virus in the female population. A thorough examination would have been ideal to rule 
out co-existence of cervical cancer because undocumented observation in our centers has 
shown cases of the later infiltrating the anal canal and admitted in surgical wards.  Our study 
has also reported the occurrence of GIST in sigmoid colon and for the first time in this country 
melanoma in the anal canal. 
 
Almost all of our patients with colorectal tumours presented late with dukes stage C and D in 
spite of most of them having tumors on the left side which usually present early due to bleeding 
per rectum, mass sensation, and bowel obstruction; though the exact nature of presentation was 
not documented. However, our findings are similar to those reported from other low incidence 
areas where screening is not being practiced14, 25-27. General patient interview to know of their 
presenting symptoms, health seeking behavior, medical attention before referral and physicians 
index of suspicion should be investigated to address this problem of late presentation. Similarly, 
a prevalence study should be carried out at multiple centers in the country to identify at risk 
patients and carry out surveillance and screening. 
 
Just well over one fifth of the patients had surgical resection of the tumor whether with 
palliative or curative intent. The reason for this low resection rate was not explored, 
undocumented reports from the physicians report patients refusal to accept proposed 
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treatment modalities, especially if it involved permanent colostomy. This is usually the standard 
of care offered to lower rectal and anal tumors since bowel anastomosis after resection of lower 
rectal tumors is usually hand sewn. Uses of stapling devices is not very famous due to their high 
cost, and are not being stocked by hospitals hence patients have to buy one and bring it with 
them for surgery. In the country as a whole, there are no specialist colorectal and anal cancer 
surgeons, hence no dedicated team of providers who have developed interest and expertise in 
the management of these patients.  This resulted into longer waiting lists for surgery and 
possibility of stage shift of the disease. The most commonly performed procedure was a 
palliative colostomy due to what was perceived to be inoperability. The practice of offering Neo-
adjuvant radiation therapy is not very popular as it can be seen that only 19.5% of the study 
subjects underwent it, unlike in other places where it was offered to more than half of the 
patients17, 28. Observation form local experience after both Neo-chemotherapy and/or 
radiotherapy is a no change in tumor status.  
 
Adjuvant chemotherapy and radiotherapy have been demonstrated to improve overall disease 
free survival in selected patients with large intestine malignances. Patients with stage I colon 
cancer have excellent 5-year survival rates (80-100%) and no adjuvant therapy is 
recommended. Usually patients with advanced stage II and stage III benefit most with 
postoperative adjuvant chemotherapy. There is evidence that stage III patients have 33% 
reduction in mortality with adjuvant therapy. Stage IV patients can also benefit from adjuvant 
chemotherapy13, 17. Recurrence of large intestine malignances following surgery is a major 
problem and often is the ultimate cause of death. So, patients who have undergone resections 
with curative intention should be followed-up closely indefinitely for evidence of tumor 
recurrence and spread13.The use of tumor markers before initiation of therapy is very 
important in the follow up period as well as endoscopic procedures that are now readily 
available in developing countries including Tanzania. In our study the role of adjuvant 
chemotherapy was not studied. 
The questions remain whether we are using the right drugs and doses, and whether EBRT can 
deliver enough doses to shrink a tumor has not been studied here. But since two thirds of 
patients with colon cancers had received a Hemicolectomy leaves a lot of questions as to 
whether it was inoperability or lack of expertise which led to low resection rates as those 
factors may influence the outcome29. Leaving the general surgeons to do advanced surgeries 
like recto-anal procedures should be looked at especially in tertiary level facilities to improve 
resection rates. 
Conclusion  
Large intestines malignancy is a common disease occurring in Tanzania with equal sex 
distribution, affecting the middle age. It occurs most commonly on the left side, with rectum 
being the commonest. Most of large intestine cancerpatients present with advanced stages of 
the disease with adenocarcinoma being the most common histological diagnosis for those who 
had colorectal tumours. A need for high index of suspicious among clinicians so as to ensure 
early diagnosis of large intestines cancers and prompt treatment is required. Health education 
to the population should be offered to promote awareness of early signs and symptoms of large 
intestines cancers hence increase rate of early diagnosis.  
More studies are needed to investigate on long term outcomes of these patients in terms of 
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Recommendation  
• Establishment of a surgical gastroenterology unit that will only be dealing with GIT 
surgery including large bowel surgery should be considered.  
• There is a need to train surgeons on lower bowel surgery.  
• Locally developed protocol for the management of large intestine cancer should be 
developed to improve and standardize type of care offered to the patients.   
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